Conclusion.
作者信息
Koenig Wolfgang, Zannad Faiez
机构信息
University of Ulm, Ulm, Germany.
出版信息
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):54-5. doi: 10.1177/2047487312448992.
PMID:22801070
Abstract
摘要
相似文献
1
Conclusion.结论。
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):54-5. doi: 10.1177/2047487312448992.
2
Risk-guided therapy: a first step to personalized medicine.风险导向治疗：迈向个性化医疗的第一步。
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):5-6. doi: 10.1177/2047487312448991.
3
New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理新指南——共识背后是否存在争议？
Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):724-7. doi: 10.1177/1741826711418946.
4
Implementation, target population, compliance and barriers to risk guided therapy.风险导向治疗的实施、目标人群、依从性和障碍。
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):37-41. doi: 10.1177/2047487312448989.
5
6
The challenge for preventive cardiology.预防心脏病学面临的挑战。
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S19-23. doi: 10.1097/01.hjr.0000359231.80893.ac.
7
Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it.对未来的期望：儿童心血管风险增加的早期识别及应对方法
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S61-4. doi: 10.1097/01.hjr.0000359240.52185.51.
8
Do novel biomarkers add to existing scores of total cardiovascular risk?新的生物标志物是否增加了现有的总体心血管风险评分？
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):14-7. doi: 10.1177/2047487312448988.
9
Reducing lifetime cardiovascular risk.降低终身心血管疾病风险。
Atherosclerosis. 2012 Jun;222(2):326-8. doi: 10.1016/j.atherosclerosis.2012.03.019. Epub 2012 Mar 23.
10
The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.女性心脏易患心血管疾病：针对女性的新出现的预防证据必须为针对女性的新出现的预防策略提供依据。
Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):118-9. doi: 10.1161/CIRCOUTCOMES.110.942664.
Zotero 插件